baber/WOPTO huggingface dataset:
Patent AU-682110-B2 (AU)
Title: Laser small arms transmitter
Inventor: PARIKH HIMNASHU N
IPC: F41A33/02
Filed: 1995-04-28
Granted: 1997-09-18
Abstract: A laser small arms transmitter (SAT) which may be affixed to the stock of a rifle such as an M16 used by a soldier in training with a multiple integrated laser engagement system (MILES). The transmitter includes a housing assembly having a forward end with a window through which the beam of a laser diode is emitted. A pair of optical wedges are positioned inside the housing assembly between the laser diode and the window. The optical wedges are supported for independent rotation about a common optical axis for steering the laser beam. An alignment head may be physically mated to the rearward end of the housing assembly for driving a pair of shafts to rotate the optical wedges in the alignment of the transmitter so that a soldier can accurately hit a target once he or she has located the target in the conventional sights of the rifle. The laser transmitter may also include a sensor for detecting the firing of a blank cartridge, a fire LED mounted inside the housing for producing an optical signal to indicate to the alignment head that the laser diode has been energized, and an inductive switch connected to a power circuit and actuable by an induction coil in the alignment head to energize the laser diode.
Patent AU-773420-B2 (AU)
Title: Prodrug compounds and process for preparation thereof
Inventor: LOBL THOMAS J
IPC: A61K47/48
Filed: 1999-12-10
Granted: 2004-05-27
Abstract: The compound of the invention is a prodrug form of a therapeutic agent linked directly or indirectly to an oligopeptide, which in turn, is linked to a stabilizing group. More generally, the present invention may be described as a new prodrug compound of a therapeutic agent, especially prodrugs comprising an antitumor therapeutic agent, displaying improved therapeutic properties relative to the products of the prior art, especially improved therapeutic properties in the treatment of cancerous tumors and/or in the treatment of inflammatory reactions such as rheumatic diseases. Improved therapeutic properties include decreased toxicity and increased efficacy. Particularly desired are prodrugs which display a high specificity of action, a reduced toxicity, an improved stability in the serum and blood, and which do not move into target cells until activated by a target cell associated enzyme. Prodrug compounds of a marker enabling tumors to be characterized (diagnosis, progression of the tumor, assay of the factors secreted by tumor cells, etc.) are also contemplated. The present invention also relates to the pharmaceutical composition comprising the compound according to the invention and optionally a pharmaceutically acceptable adjuvant or vehicle. Further, a method of decreasing toxicity by modifying a therapeutic agent to create a prodrug is disclosed. Several processes for creating a prodrug of the invention are described. Compounds of the invention include the prodrugs, Suc-ssAla-Leu-Ala-Leu-Dox, Suc-ssAla-Leu-Ala-Leu-Dnr, and Glutaryl-ssAla-Leu-Ala-Leu-Dox. Additionally intermediate compounds, important to the process of preparation of the prodrugs of the invention are claimed.
Patent AU-625807-B2 (AU)
Title: Uses of recombinant colony stimulating factor-1
Inventor: RALPH PETER
IPC: A61K38/20
Filed: 1988-09-16
Granted: 1992-07-16
Abstract: Recombinantly produced colony stimulating factor 1 (CSF-1) is useful in the form of a medicament for the treatment of leukopenia including enhancement of white blood cell count.
Patent AU-621318-B2 (AU)
Title: Control of ectoparasites
Inventor: BOISVENUE RUDOLPH JOSEPH
IPC: C07C49/807
Filed: 1988-11-18
Granted: 1992-03-12
Abstract: A series of 1,3-propanediones having a perfluoroalkyl group or a perfluorocycloalkyl group on one carbonyl, and a 3,5-disubstituted phenyl group on the other, are useful when administered to animals for the control of ectoparasites.
Patent AU-666676-B2 (AU)
Title: Biodegradable polymer composition
Inventor: DUNN RICHARD L
IPC: A61K45/00
Filed: 1992-09-30
Granted: 1996-02-22
Abstract: The invention is directed to a composition composed of a thermoplastic or thermosetting polymer which is capable of forming a biodegradable and/or bioerodible microporous, solid or gelatinous polymer matrix. The matrix is useful as an implant in animals for enhancing regeneration of cells and tissue, such as bone and nerve cells, or for delivery of biologically-active substances to tissue or organs. The composition is administered to an implant site as a liquid. The invention also includes a method of preventing and treating disorders and diseases, such as bone or nerve growth disorders, or of altering body functions such as birth control, using the compositions and implants of the invention.
Patent AU-694236-B2 (AU)
Title: Stamping foil, in particular a hot-stamping foil with decorative or security elements
Inventor: SUSS JOACHIM
IPC: B44C1/17
Filed: 1995-06-10
Granted: 1998-07-16
Abstract: PCT No. PCT/DE95/00784 Sec. 371 Date Dec. 20, 1996 Sec. 102(e) Date Dec. 20, 1996 PCT Filed Jun. 10, 1995 PCT Pub. No. WO96/01187 PCT Pub. Date Jan. 18, 1996There is disclosed a hot stamping foil assembly, in particular a hot stamping foil, which has spatial decorative or security elements formed in a region-wise manner. An adhesive layer is provided only in a region-wise manner and in matching relationship with respect to the spatial elements to effect transfer of the spatial decorative or security elements or other decorative layer structure.
Patent AU-722504-B2 (AU)
Title: Conical filter
Inventor: TOKAR JOSEPH C
IPC: B01D46/00
Filed: 1997-04-25
Granted: 2000-08-03
Abstract: A filter element having flow passing from upstream to downstream through the filter element, comprising:   Filter media comprising s plurality of flutes extending in longitudinal direction; wherein the filter media is coiled in a spiralling configuration having an outer surface and a first and second face. First ends of the flutes extend to the first face and second ends of the flutes extend to the second face, and alternating ends of the flutes are closed, and a portion of the first face of the coil slopes outward and toward the second face, wherein the flow passes substantially parallel to the flute direction from the first face to the second face, wherein a center potion of the first face has a substantially conical configuration, and wherein the filter element is structurally self-supporting in the substantially conical configuration.   <IMAGE>
Patent AU-559206-B2 (AU)
Title: Treated collagen based surgical thread
Inventor: HUNTER ALASTAIR WILSON
IPC: A61L17/14
Filed: 1984-06-05
Granted: 1987-02-26
Abstract: A collagen-based surgical thread is disclosed which contains absorbed therein water, a hygroscopic agent, and a nonionic surfactant in an amount sufficient to enhance the pliability of the thread, and, in many cases, the tie down performance.
Patent AU-782177-B2 (AU)
Title: Water soluble prodrugs of azole compounds
Inventor: UEDA YASUTSUGU
IPC: C07D249/08
Filed: 2001-01-16
Granted: 2005-07-07
Abstract: Water-soluble prodrugs of triazole antifungal compounds having a secondary or tertiary hydroxy group are provided. More particularly, new water-soluble triazole antifungal compounds are provided having the general formulawherein A is the non-hydroxy portion of a triazole antifungal compound of the type containing a secondary or tertiary hydroxyl group and R and R1 are as defined in the specification.
Patent AU-695214-B2 (AU)
Title: Catalysts and processes for the polymerization of olefins
Inventor: OCCO TIZIANO DALL
IPC: C08F110/02
Filed: 1995-07-18
Granted: 1998-08-06
Abstract: Catalysts for the polymerization of olefins which comprise the reaction product of (a) a bridged and/or substituted cyclopentadienyl compound of titanium, zirconium, or hafnium; (b) an organometallic aluminum compound of formula Al(CH2-CR4R5R6)wR7yHz, wherein in the (CH2-CR4R5R6) groups, which are the same or different, R4 is an alkyl, alkenyl or arylalkyl group having from 1 to 10 carbon atoms, R5 is an alkyl, alkenyl, aryl, arylalkyl or alkylaryl group having from 3 to 50 carbon atoms and, optionally, R4 and R5 can be fused together to form a ring having from 4-6 carbon atoms, R6 is hydrogen or an alkyl alkenyl or arylalkyl group having from 1 to 10 carbon atoms, the R7 substituents, the same or different, are alkyl, alkenyl, aryl, arylalkyl or alkylaryl radicals having from 1 to 10 carbon atoms and, optionally, can contain Si or Ge atoms, w is 1, 2 or 3, z is 0 or 1, and y=3-w-z; and (c) water. The molar ratio of aluminum to water is from 1:1 to 100:1. The catalysts show an improved activity with respect to known catalysts wherein an aluminum compound different from those of the invention are used.
Patent AU-683588-B2 (AU)
Title: Chromatographic resins and methods for using same
Inventor: BURTON SIMON C
IPC: B01J20/285
Filed: 1995-09-20
Granted: 1997-11-13
Abstract: Disclosed are rationally designed mixed mode resins which are useful in recovering a target compound from an aqueous solution and methods for use of such resins. The resins described herein have a hydrophobic character at the pH of binding of the target compound and a hydrophilic and/or electrostatic character at the pH of desorption of the target compound from the resin and are specifically designed to bind the target compound from an aqueous solution at both a low and high ionic strength.
Patent AU-671438-B2 (AU)
Title: New use of omega-3-fatty acids
Inventor: EGBERG NILS
IPC: A61P7/02
Filed: 1993-02-23
Granted: 1996-08-29
Abstract: PCT No. PCT/SE93/00146 Sec. 371 Date Oct. 21, 1994 Sec. 102(e) Date Oct. 21, 1994 PCT Filed Feb. 23, 1993 PCT Pub. No. WO93/16691 PCT Pub. Date Sep. 2, 1993The present invention relates to omega-3-fatty acid containing preparations for the treatment of Disseminated Intravascular Coagulation (DIC) and symptoms related to DIC, as well as such preparations for reducing a pathological increase in pulmonary artery pressure (PAP). The preparations may be in the form of emulsions, or aerosols for inhalation, of an oil or phospholipids or other derivatives or salts of omega-3-fatty acids of marine and/or vegetable origin with a significant content of omega-3-fatty acids. The preparations may also be in tablet or capsule form for oral use.
Patent AU-572244-B2 (AU)
Title: Antimicrobial animal feed additive
Inventor: INGLE DONALD LEE
IPC: C07C215/28
Filed: 1984-12-21
Granted: 1988-05-05
Abstract: Antimicrobial animal feed additive compositions containing substituted 1-(aminophenyl)-2-aminoethanols and a method for increasing feed efficiency and antilipogenic activity when said animal feed additive combinations are orally administered to food-producing animals.
Patent AU-621648-B2 (AU)
Title: Pharmaceutical formulation for the treatment of diabetes mellitus
Inventor: DORSCHUG MICHAEL
IPC: C07K14/62
Filed: 1989-08-11
Granted: 1992-03-19
Abstract: Pharmaceutical formulations for the treatment of diabetes mellitus are disclosed, wherein the pharmaceutical formulations contain at least one insulin derivative modified with a base in position B31 of the insulin B chain and having an isoelectric point between 5.8 and 8.5 and/or at least one of its physiologically tolerated salts in a pharmaceutically acceptable excipient and a relatively high zinc ion content in the range from above 1  mu g to about 200  mu g of zinc/IU. The preferred insulin derivative modified with a base for this pharmaceutical formulation is human insulin-B31-Arg-OH and human insulin-B31-Arg-B32-Arg-OH. The formulation is used for the treatment of diabetes mellitus; it has a particularly favorable action profile.
Patent AU-666197-B2 (AU)
Title: Partly denaturized whey-protein product
Inventor: HOLST HANS HENRIK
IPC: A23L27/60
Filed: 1993-05-05
Granted: 1996-02-01
Abstract: PCT No. PCT/EP93/01093 Sec. 371 Date Dec. 1, 1994 Sec. 102(e) Date Dec. 1, 1994 PCT Filed May 5, 1993 PCT Pub. No. WO93/25086 PCT Pub. Date Dec. 23, 1993.A partially denatured whey protein product with a protein content of 65-95% by weight relative to the dry matter, a protein denaturization level of 55-80%, and a mean particle size in the range from 30 to 60  mu m, in particular 40-50  mu m. The product is suitable for use in foods as an additive with an emulsifying action and good organoleptic properties, particularly in cold-prepared emulsions.
Patent AU-710669-B2 (AU)
Title: Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
Inventor: SAULNIER MARK GEORGE
IPC: A61K31/7052
Filed: 1997-08-21
Granted: 1999-09-23
Abstract: The present invention concerns novel amino sugar and related sugar derivatives of indolopyrrolocarbazoles, their use as antitumor agents, and pharmaceutical formulations.
Patent AU-620924-B2 (AU)
Title: Indwelling ureteral stent placement apparatus
Inventor: ROEMER FREDERICK D
IPC: A61F2/95
Filed: 1989-10-17
Granted: 1992-02-27
Abstract: An indwelling ureteral stent positioning apparatus (10) is provided for allowing single intrusion placement of a stent (20) in the ureter of a patient. The apparatus is pre-assembled and includes a wire guide (12) with floppy tip (14). The stent (20) is positioned about the wire guide (12) adjacent to the floppy tip (14) of the wire guide (12), and is adjustably situated on the wire guide (12) to expose a pre-determined length of the floppy tip (14) for insertion into the patient. The stent (20) is a dual open-ended tubular stent having a resilient retentive curved circular or pigtail shape at each end for retention in the kidney and bladder. A positioner (25) is conveyed on the wire stent until the end of the positioner abuts the anatomically distal end (24) of the stent (20). A pin-vise clamp (30) abuts the external end of the positioner (25) and releasably engages the wire guide (12) to stabilize the apparatus (10) during insertion. When used to position the stent (20) within the ureter, the apparatus (10) is conveyed along the ureter until the floppy tip (14) is within the renal collecting system. The positioner (25) is advanced along the wire guide (12) to push the anatomically proximal end (23) of the stent (20) over and beyond the floppy tip (14) so that the retentive coil forms within the kidney. The pin-vise clamp (30) is released to allow the wire guide (12) to be withdrawn until it passes the anatomically distal end (24) of the stent (20), wherein the retentive coil shape is formed within the bladder. With the stent fully indwelling, the positioner (25) and wire guide (12) are removed from the patient. <IMAGE>
Patent AU-592952-B2 (AU)
Title: Monoclonal antibody stabilization
Inventor: DODGE ROBERT H
IPC: G01N33/577
Filed: 1985-07-25
Granted: 1990-02-01
Abstract: A solution containing from about 0.25% to about 5% hydrolyzed ovalbumin by weight provides surprising thermal stabilization of monoclonal antibodies.
Patent AU-711388-B2 (AU)
Title: Method and apparatus for the control of flammable fluid heating apparatus
Inventor: FLEMING JOHN STUART
IPC: F23N5/10
Filed: 1996-02-20
Granted: 1999-10-14
Abstract: This invention provides a sensor for the depletion of oxygen in a room in which a flammable fluid heater is housed. The heater is provided with a pilot burner which is sensitive to oxygen levels and a temperature sensor (2) which senses the output from the pilot burner. The output from the temperature sensor (2) itself can be used as an indicator of oxygen depletion within the room and compared against a stored value to close off the fuel supply to the heater should the temperature sensor (2) output fall below a predetermined level. Additional features include the provision of a carbon monoxide sensor (9) linked to the heater so that the sensor is only in operation when the heater itself is turned on. Further, a second temperature sensor (14) to sense whether the appliance is in operation may be used to extinguish the pilot burner if it determines the appliance is not in use. <IMAGE>
Patent AU-703419-B2 (AU)
Title: Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy
Inventor: ROLLAND ALAIN
IPC: A61K47/48
Filed: 1995-12-28
Granted: 1999-03-25
Abstract: Compositions and methods for administering nucleic acid compositions in vitro to cells in culture or in vivo to an organism whereby the uptake of nucleic acids is enhanced are provided. Various compositions, including thermo-reversible gels, are utilized to increase the viscosity of an administered nucleic acid formulation, thereby prolonging the localized bioavailability of the administered nucleic acid.
Patent AU-751485-B2 (AU)
Title: Crystal modification of lipoic acid
Inventor: KLATT MARTIN JOCHEN
IPC: C07D339/04
Filed: 1999-07-12
Granted: 2002-08-15
Abstract: In the 2 Θ diffractogram of an enantiomerically pure crystalline (R)- or (S)-lipoic acid, the most intense reflection line in the range from 13° to 30° is that at 2 Θ=23°.
Patent AU-664657-B2 (AU)
Title: Belt tensioning system, belt tensioner therefor and methods of making the same
Inventor: GARDNER DAVID E
IPC: F16H7/08
Filed: 1993-09-17
Granted: 1995-11-23
Abstract: A belt tensioning system, a belt tensioner therefor and methods of making the same are provided, the belt tensioning system comprising a tensioner arm pivotally mounted to a support, and a wound coiled spring having opposed ends one of which is operatively interconnected to an abutment of the support and the other of which is operatively interconnected to the arm, the arm having a shoulder for being engaged by the one of the opposed ends of the wound coiled spring so as to permit removal of the arm and the wound coiled spring as a self-contained unit from the support when the arm is pivoted to a certain position where the shoulder of the arm engages the one end of the spring and effectively moves the one end of the wound coiled spring out of contact with the abutment of the support, the wound coiled spring comprising a helical spring having the opposed ends thereof comprising an inner end and an outer end, the one end of the wound coiled spring comprising the outer end thereof.
Patent AU-674713-B2 (AU)
Title: Method of and apparatus for reducing iron fouling in groundwater treatment systems
Inventor: MAZEWSKI EUGENE E
IPC: C02F1/64
Filed: 1994-01-17
Granted: 1997-01-09
Abstract: Disclosed herein is a treatment facility comprising a fluid bed reactor (13) including a reactor tank (15) containing a bed of particles which function as a carrier for growth of biological material, the reactor tank having an inlet and an outlet, the reactor further including structure for conducting liquid to be treated, from the reactor tank inlet, upwardly through the bed of particles at a rate conducive to fluidization of the bed of particles; an equalization surge tank (31) for housing liquid to be treated in the fluid bed reactor, the equalization surge tank having an inlet, and an outlet; conduit structure for supplying liquid from the outlet of the equalization surge tank to the inlet of the fluid bed reactor; and structure for supplying an oxidant into the equalization surge tank, in such a manner that stripping of volatile constituents is avoided, for oxidizing iron in the liquid in the equalization surge tank. <IMAGE>
Patent AU-527524-B2 (AU)
Title: Feedstuff plus parenteral dosing treatment of animals
Inventor: DELAY ROGER LEE
IPC: A23K20/195
Filed: 1980-01-18
Granted: 1983-03-10
Abstract: The invention provides a combination treatment for ruminants to synergistically enhance the growth rate thereof and improve the efficiency of feed utilization thereby. The treatment involves, orally administering a growth-enhancing amount of the antibiotic AV290, antibiotic AV290 sulfate, antibiotic AV290-syntan complex, antibiotic AV290-alkylsulfate complex and/or antibiotic AV290 alkylated derivative, to ruminants which have been parenterally or orally treated with a growth-enhancing amount of certain selected steroids or steroidal compositions.
Patent AU-726754-B2 (AU)
Title: Method for production of stay-fresh baked goods
Inventor: SCHUSTER ERWIN
IPC: A21D8/04
Filed: 1997-11-13
Granted: 2000-11-23
Abstract: The invention relates to a method for the production of baked goods from cereal products with use of enzymes, with the aim of preventing the baked goods from going stale. To this effect, a Thermoactinomyces vulgaris alpha amylase is added, which makes possible targeted partial hydrolysis of the starch, and in the process prevents its retrogradation to a large extent, and is simultaneously deactivated by the baking process.
Patent AU-672267-B2 (AU)
Title: Triazolopyrimidine derivatives
Inventor: PEES KLAUS-JURGEN
IPC: A01P3/00
Filed: 1994-02-23
Granted: 1996-09-26
Abstract: This invention relates to certain triazolopyrimidine derivatives of the general formula <CHEM> in which R<1> represents an optionally substituted alkyl, alkenyl, alkynyl, alkadienyl, cycloalkyl, bicycloalkyl or heterocyclyl group; R<2> represents a hydrogen atom or an alkyl group; or R<1> and R<2> together with the interjacent nitrogen atom represent an optionally substituted cycloalkyl or heterocyclic ring; R<3> represents an optionally substituted cycloalkyl or heterocyclyl group; and R<4> represents a hydrogen or halogen atom or a group -NR<5>R<6> where R<5> represents a hydrogen atom or an amino, alkyl, cycloalkyl or bicycloalkyl group and R<6> represents a hydrogen atom or an alkyl group; processes for their preparation; compositions containing such compounds and their use as fungicides.
Patent AU-733297-B2 (AU)
Title: A CD-ROM software protection system
Inventor: SKALKOS PETROS
IPC: G06F1/00
Filed: 1996-05-28
Granted: 2001-05-10
Abstract: This Protection System, for PC Software stored in CD-ROM, prevents the illegal copying (hacking) with negligible cost increase of the protected Application. The same CD-ROM that contains the Application Software serves as a "protection key". The CD-ROM disk undergoes a special treatment during its production phase that results in the generation of the Inspection Ring. This system uses a special method for the verification of the authenticity of the Inspection Ring. The existence of the Inspection Ring along with the use of the authenticity verification procedure make impossible the copying of the CD-ROM disk even with the most advanced recording equipment. This system has many advantages over other protection methods like: excellent protection, transparency to the end-user and very low cost since the "protection-key" is the same CD-ROM disk that contains the Application. This system can be used for the protection of every Application Software for PC compatibles that is stored in a CD-ROM and runs under DOS or Windows environments.
Patent AU-636386-B2 (AU)
Title: Food grade laked pigment dispersion composition
IPC: A61K8/58
Filed: 1990-08-06
Granted: 1993-04-29
Abstract: Improved stable, fluid, aqueous dispersion compositions comprise a pigment, an alkali metal, alkaline earth metal or ammonium salt of a linear aliphatic substituted glycine such as a salt of ethylene diamine tetraacetic acid or nitrilo triacetic acid as a stabilizing agent, and water. The dispersion composition may additionally contain a lower alkanol such as methanol and/or a water soluble plasticizer such as propylene glycol. Coating compositions for use as a film coating for tablets and the like contain the above-described stable, fluid, aqueous dispersion composition, a water soluble plasticizer, a film coating resin, and water. The described fluid, aqueous dispersion compositions have been found to remain stable for extended periods exceeding six months.
Patent AU-707399-B2 (AU)
Title: Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
Inventor: HAEN CHRISTOPH DE
IPC: A61K35/74
Filed: 1996-06-19
Granted: 1999-07-08
Abstract: PCT No. PCT/EP96/02650 Sec. 371 Date Dec. 12, 1997 Sec. 102(e) Date Dec. 12, 1997 PCT Filed Jun. 19, 1996 PCT Pub. No. WO97/00688 PCT Pub. Date Jan. 9, 1997The present invention refers to pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders.